Tycoon Group Entered into a Strategic Cooperation Framework

/PRNewswire/ -- Tycoon Group Holdings Limited ("Tycoon" or the "Company" and its subsidiaries (together, the "Group"), Stock Code: 3390), an omnichannel brand...

Related Keywords

China , Guangdong , Jilin , Hong Kong , Macau , Macao , Macau General , Chinese , Hong Kong Guobiao , Guangdong Hong Kong , Wong Ka Chun Michael , Sophia Chan , Tycoon Group , China Resources Pharmaceutical Group , China National Accreditation Services For Conformity Assessment , Year Plan National Science , China Resources Pharmaceutical Group Limited Stock Code , China Resources Group Company , National Key Laboratory Of Innovative Medicines , Tycoon Group Holdings Limited Stock Code , Prnewswire Tycoon Group Holdings Limited , Testing Co , China Resources Pharmaceutical Group Limited , Testing Co Ltd Guobiao , China Resources Pharmaceuticals , Tycoon Asia Pacific Group , Ah Companies Index , Guangdong Provincial Medical Products Administration , Morgan Stanley Capital International , Laboratory Mandatory Approval Of China , Technology Support Programme , Tycoon Group Holdings , Dimensions Of Development , Mainland China Companies Index , National Medical Products Administration , Chinese Medicine Council Of Hong Kong , Development Work Plan , Testing Co Ltd , Group Holdings Limited , Stock Code , Tycoon Asia Pacific Group Limited , Hong Kong Guobiao Inspection , Guangdong Hong Kong Macau , Greater Bay Area , Iron Triangle Helped Tycoon , Blue Ocean Market , Proprietary Chinese Medicine , Framework Agreement , China Resources Pharmaceutical , Hong Kong Macau Greater Bay Area Medicines , Medical Devices Regulatory Innovation , Development Work , Professor Sophia Chan , Chinese Medicine , Chinese Medicine Sector , China Government , Construction Plan , Chinese Medicine Council , Guangdong Hong Kong Macao , Strategic Cooperation Framework Agreement , Great Bay , Mainland China , Guangzhou Guobiao Inspection , Key Laboratory , Innovative Medicines , Cost Reducing Pharmaceutical Equipment , Analytical Testing , China Inspection Body , Laboratory Mandatory Approval , China National Accreditation Services , Conformity Assessment , Chief Executive Officer , Ocean Market , Tycoon Group Holdings Limited , Private Label Products , China Resources Group , Resources Pharmaceutical , Hang Seng Composite Large Cap Index Constituents , Hang Seng China Mainland Healthcare Index , Hang Seng Healthcare Index , Equity Index , Large Stocks , World Index , All Cap Index , China Index Constituent , Hang Seng , China Companies Index , Group Holdings ,